4-(5-Chloro-6-(2-methylpropoxy)-3-pyridinyl)-N-(methylsulfonyl)-3-(trifluoromethoxy)benzamide

ID: ALA4539119

PubChem CID: 155550095

Max Phase: Preclinical

Molecular Formula: C18H18ClF3N2O5S

Molecular Weight: 466.87

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)COc1ncc(-c2ccc(C(=O)NS(C)(=O)=O)cc2OC(F)(F)F)cc1Cl

Standard InChI:  InChI=1S/C18H18ClF3N2O5S/c1-10(2)9-28-17-14(19)6-12(8-23-17)13-5-4-11(16(25)24-30(3,26)27)7-15(13)29-18(20,21)22/h4-8,10H,9H2,1-3H3,(H,24,25)

Standard InChI Key:  NAEGMPJMPOMSEN-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 30 31  0  0  0  0  0  0  0  0999 V2000
   25.3659  -11.4737    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.1831  -11.4778    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   25.7781  -10.7681    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.7785  -13.9335    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7773  -14.7530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4854  -15.1620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1950  -14.7525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1922  -13.9299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4836  -13.5246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4870  -15.9770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7776  -16.3848    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7771  -17.2013    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.4852  -17.6108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1954  -17.1980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1924  -16.3829    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4811  -12.7074    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1876  -12.2967    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.7722  -12.3010    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.8917  -11.0688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.9044  -17.6043    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   25.4861  -18.4280    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.7788  -18.8374    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0707  -18.4296    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3634  -18.8389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0698  -17.6124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0693  -15.1611    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.3619  -14.7519    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6539  -15.1599    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   23.3625  -13.9347    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   22.6502  -14.3421    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  6 10  1  0
  9 16  1  0
 16 17  1  0
 16 18  2  0
 17  2  1  0
  2 19  1  0
 14 20  1  0
 13 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 23 25  1  0
  5 26  1  0
 26 27  1  0
 27 28  1  0
 27 29  1  0
 27 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4539119

    ---

Associated Targets(Human)

SCN9A Tclin Sodium channel protein type IX alpha subunit (8393 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SCN5A Tclin Sodium channel protein type V alpha subunit (3462 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 466.87Molecular Weight (Monoisotopic): 466.0577AlogP: 4.02#Rotatable Bonds: 7
Polar Surface Area: 94.59Molecular Species: ACIDHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 4.12CX Basic pKa: 0.66CX LogP: 4.45CX LogD: 3.51
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.66Np Likeness Score: -1.21

References

1. DiMauro EF, Altmann S, Berry LM, Bregman H, Chakka N, Chu-Moyer M, Bojic EF, Foti RS, Fremeau R, Gao H, Gunaydin H, Guzman-Perez A, Hall BE, Huang H, Jarosh M, Kornecook T, Lee J, Ligutti J, Liu D, Moyer BD, Ortuno D, Rose PE, Schenkel LB, Taborn K, Wang J, Wang Y, Yu V, Weiss MM..  (2016)  Application of a Parallel Synthetic Strategy in the Discovery of Biaryl Acyl Sulfonamides as Efficient and Selective NaV1.7 Inhibitors.,  59  (17): [PMID:27441383] [10.1021/acs.jmedchem.6b00425]

Source